Skip to content. Skip to main navigation.

UTA In The News — Wednesday, August 3, 2016

Wednesday, August 3, 2016

Bookmark and Share

Women's study

Linda Perrotti, UTA associate professor of psychology, is studying how fluctuating estrogen levels make females increasingly sensitive to the rewarding effects of cocaine and ultimately, vulnerable to cocaine addiction,, and  reported. 

Return policies

Narayan Janakiraman, an assistant professor in UTA’s Department of Marketing, and Holly Syrdal, a UTA doctoral student published an article in the Harvard Business Review about how to design a return policy. 

Suspension discussed

Allan Saxe, UTA associate professor of political science, called the suspension of a University of Houston student body vice president for comments she made about the Black Lives Matter movement a clear violation of the First Amendment, WBAP/820 AM reported.

UTA grad starts scholarship

Richard J. Matus, a corporate executive who received his doctorate in aerospace engineering from UTA, has established the Richard J. Matus ’80 Scholarship in Aerospace Engineering through the Texas A & M Foundation, Texas A & M reported on its website.

Local music archive

David Arditi, a UTA assistant professor of sociology, is developing a musical archive of UTA music students, professors, alumni and North Texas musicians called MusicDetour – The DFW Local Music Archive, Dallas Innovates reports. 

New chemistry test referenced a Science Daily story about UTA chemists discovering cheaper ways to determine the amount of water in solid pharmaceutical drugs. The discovery is cheaper, faster, more precise, and more accurate than Karl Fischer titration.

UTA part of imaging grant

The Texas Tribune cited a D Healthcare Daily story that said UT Southwestern, one of two locations in the U.S. to win a $1 million planning grant from the National Institutes of Health for a National Particle Therapy Research Center, will collaborate with Mingwu Jin, a UTA assistant professor of physics, to develop an imaging system to show how patients are responding to treatments in real time.